找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antiviral Strategies; Hans-Georg Kr?usslich,Ralf Bartenschlager Book 2009 Springer-Verlag Berlin Heidelberg 2009 Antiviral Drug.DNA.Drug R

[復(fù)制鏈接]
樓主: eternal
31#
發(fā)表于 2025-3-26 21:35:28 | 只看該作者
32#
發(fā)表于 2025-3-27 01:28:54 | 只看該作者
33#
發(fā)表于 2025-3-27 05:47:12 | 只看該作者
https://doi.org/10.1007/11545156 infection and can also be used to treat certain forms of chronic hepatitis B virus infections. IFNs have also been used in other viral infections, although with less success. The antiviral mechanisms of IFNs are reviewed in this chapter as well as the utility of IFNs in the treatment of persistent viral infections.
34#
發(fā)表于 2025-3-27 12:41:50 | 只看該作者
35#
發(fā)表于 2025-3-27 17:15:16 | 只看該作者
36#
發(fā)表于 2025-3-27 18:48:14 | 只看該作者
37#
發(fā)表于 2025-3-27 23:23:43 | 只看該作者
Lecture Notes in Computer Sciencee cycles and, in the context of HIV treatment, contributes to the growing armamentarium of antivirals which, in multidrug combinations, can effectively inhibit viral replication and prevent disease progression.
38#
發(fā)表于 2025-3-28 02:38:13 | 只看該作者
39#
發(fā)表于 2025-3-28 08:59:27 | 只看該作者
Jeremy Rose,Jesper Holgersson,Eva S?derstr?mpidly and will provide further opportunities to explore the efficacy of combination antiviral therapy. While sufficient suppression of HIV RNA and HBV DNA can only be achieved by long-term administration of potent antiviral drugs, HCV RNA may be completely eradicated from the infected individual after a limited duration of treatment.
40#
發(fā)表于 2025-3-28 13:52:13 | 只看該作者
Approaches for the Development of Antiviral Compounds: The Case of Hepatitis C Virus,in Phases 1, 2, and 3, leading to the goal of approved drugs that benefit the infected individual. This review uses hepatitis C virus (HCV), for which we still do not have an ideal therapeutic modality, as an example of the multidisciplinary efforts needed to discover new antiviral drugs for the benefit of humanity.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-25 00:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
安阳市| 柳州市| 平泉县| 安阳县| 赤水市| 南丹县| 永年县| 罗城| 新安县| 黄山市| 婺源县| 海兴县| 从江县| 平武县| 尉氏县| 大城县| 隆子县| 抚州市| 鹤岗市| 九龙城区| 金昌市| 营山县| 安阳市| 玉溪市| 平阴县| 静宁县| 鸡东县| 丹巴县| 三河市| 呼玛县| 大渡口区| 社旗县| 凉山| 揭西县| 尉犁县| 敖汉旗| 莱州市| 岑巩县| 喀喇沁旗| 格尔木市| 德惠市|